U.S. Physical Therapy, Inc. (USPH)

NYSE: USPH · Real-Time Price · USD

85.09

-1.36 (-1.57%)

At close: Feb 20, 2026, 4:00 PM EST

85.16

+0.07 (0.08%)

After-hours: Feb 20, 2026, 7:00 PM EST

U.S. Physical Therapy Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	623.05	553.64	508.38	459.04	433.03	368.72
Other Revenue	127.9	110.79	90.25	88.55	56.69	49.63
Revenue	750.95	664.43	598.63	547.6	489.72	418.35
Revenue Growth (YoY)	17.51%	10.99%	9.32%	11.82%	17.06%	-12.32%
Cost of Revenue	586.04	518.3	461.99	421.56	372.54	323.9
Gross Profit	164.91	146.13	136.64	126.04	117.18	94.45
Selling, General & Admin	66.71	58.29	51.95	46.11	46.53	42.04
Operating Expenses	89.01	76.14	66.91	60.05	46.53	42.04
Operating Income	75.9	69.99	69.73	65.99	70.65	52.41
Interest Expense	-9.16	-8.02	-9.3	-5.78	-0.94	-1.63
Interest & Investment Income	0.39	3.94	3.77	-	-	0.14
Earnings From Equity Investments	1.42	1.01	0.96	1.18	0.11	-
Other Non Operating Income (Expenses)	-0.91	0.28	2.97	0.85	1.42	-
EBT Excluding Unusual Items	67.64	67.2	68.13	62.24	71.23	50.92
Merger & Restructuring Charges	-0.52	-4.36	-0.18	-0.07	-	-
Impairment of Goodwill	-	-	-17.5	-9.11	-	-
Gain (Loss) on Sale of Investments	-0.12	-	-	-	-	1.09
Asset Writedown	-2.42	-2.42	-	-	-	-
Legal Settlements	-	-	-	-	-2.64	-
Other Unusual Items	16.6	-0.22	-1.08	2.52	4.6	13.5
Pretax Income	81.18	60.21	49.38	55.57	73.2	65.51
Income Tax Expense	19.85	14.61	12.16	12.16	15.27	13.02
Earnings From Continuing Operations	61.32	45.6	37.22	43.41	57.92	52.49
Minority Interest in Earnings	-16.65	-14.18	-8.98	-11.25	-17.09	-17.3
Net Income	44.67	31.42	28.24	32.16	40.83	35.19
Preferred Dividends & Other Adjustments	8.66	3.7	10.1	2.9	9.69	3.42
Net Income to Common	36.02	27.73	18.14	29.26	31.14	31.78
Net Income Growth	95.63%	11.28%	-12.19%	-21.24%	16.02%	-12.10%
Shares Outstanding (Basic)	15	15	14	13	13	13
Shares Outstanding (Diluted)	15	15	14	13	13	13
Shares Change (YoY)	0.77%	6.17%	9.26%	0.68%	0.49%	0.62%
EPS (Basic)	2.38	1.84	1.28	2.25	2.41	2.48
EPS (Diluted)	2.38	1.84	1.28	2.25	2.41	2.48
EPS Growth	153.49%	43.97%	-43.27%	-6.49%	-2.66%	1.06%
Free Cash Flow	56.9	65.75	72.68	50.29	68.21	92.36
Free Cash Flow Per Share	3.75	4.37	5.12	3.87	5.29	7.20
Dividend Per Share	1.790	1.760	1.720	1.640	1.460	0.320
Dividend Growth	2.29%	2.33%	4.88%	12.33%	356.25%	-71.93%
Gross Margin	21.96%	21.99%	22.83%	23.02%	23.93%	22.58%
Operating Margin	10.11%	10.53%	11.65%	12.05%	14.43%	12.53%
Profit Margin	4.80%	4.17%	3.03%	5.34%	6.36%	7.60%
Free Cash Flow Margin	7.58%	9.90%	12.14%	9.18%	13.93%	22.08%
EBITDA	99.34	88.67	85.43	80.73	82.24	62.95
EBITDA Margin	13.23%	13.35%	14.27%	14.74%	16.79%	15.05%
D&A For EBITDA	23.44	18.68	15.7	14.74	11.59	10.53
EBIT	75.9	69.99	69.73	65.99	70.65	52.41
EBIT Margin	10.11%	10.53%	11.65%	12.05%	14.43%	12.53%
Effective Tax Rate	24.46%	24.26%	24.62%	21.89%	20.87%	19.88%
Revenue as Reported	671.35	671.35	604.8	553.14	495.02	422.97

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q